CANRIB(Olaparib)

Ovarian cancer

• For the maintenance treatment of BRCA-mutated advanced epithelial ovarian
• For the maintenance treatment of adult patients who are in complete or partial response to platinum-based chemotherapy.
• For the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.



Breast cancer

• For the treatment of adult patients with deleterious or suspected deleterious gBRCAm, HER2-negative metastatic breast cancer who have been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
• Pancreatic cancer
• gBRCAm metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen.



Prostate cancer

• (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with enzalutamide or abiraterone.